Financials
- Market Capitalization 444.87 M
- Employee 71
- Founded 2010
- CEO N/A
- Website www.rezolutebio.com
- Headquarter Nevada, United States
- FIGI BBG001XWWHL4
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-4.55
売上高対価格比率
—
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 2983 | DNA Ginkgo Bioworks Holdings, Inc. Class A Common Stock | 6.98 USD | -3.99% | -4.12% | -10.40% | -21.40% | 449.10 M USD | ||
| 2984 | OCGN Ocugen, Inc. - Common Stock | 1.32 USD | -3.65% | -6.38% | +8.20% | +30.69% | 447.63 M USD | ||
| 3011 | PRLD Prelude Therapeutics Incorporated - Common Stock | 5.47 USD | -13.72% | -17.50% | +16.14% | +355.83% | 436.53 M USD | ||
| 3020 | CMPX Compass Therapeutics, Inc. - Common Stock | 2.40 USD | -4.76% | -0.41% | +24.35% | -30.43% | 432.21 M USD |